Your browser doesn't support javascript.
The assistance gaps in combating COVID-19 in Brazil: for whom, where and when vaccination occurs.
Moreira, Rafael da Silveira; Costa, Emilly Guaris; Dos Santos, Lucas Fernando Rodrigues; Miranda, Luiz Henrique Lélis; de Oliveira, Raiany Rodrigues; Romão, Ricardo Fusano; Cozer, Rodolfo Ferreira; Guedes, Sarah Cavalcanti.
  • Moreira RDS; Public Health Department, Instituto Aggeu Magalhães, Fundação Oswaldo Cruz, Recife, Pernambuco, Brazil. rafael.moreira@fiocruz.br.
  • Costa EG; Centre for Medical Sciences, Universidade Federal de Pernambuco, Recife, Pernambuco, Brazil. rafael.moreira@fiocruz.br.
  • Dos Santos LFR; Centre for Medical Sciences, Universidade Federal de Pernambuco, Recife, Pernambuco, Brazil.
  • Miranda LHL; Public Health Department, Instituto Aggeu Magalhães, Fundação Oswaldo Cruz, Recife, Pernambuco, Brazil.
  • de Oliveira RR; Centre for Medical Sciences, Universidade Federal de Pernambuco, Recife, Pernambuco, Brazil.
  • Romão RF; Centre for Medical Sciences, Universidade Federal de Pernambuco, Recife, Pernambuco, Brazil.
  • Cozer RF; Centre for Medical Sciences, Universidade Federal de Pernambuco, Recife, Pernambuco, Brazil.
  • Guedes SC; Centre for Medical Sciences, Universidade Federal de Pernambuco, Recife, Pernambuco, Brazil.
BMC Infect Dis ; 22(1): 473, 2022 May 17.
Article in English | MEDLINE | ID: covidwho-1846805
ABSTRACT

BACKGROUND:

Following the emergence of the COVID-19 pandemic, the number of infected Brazilian people has increased dramatically since February 2020, with Brazil being amongst the countries with the highest number of cases and deaths. Brazilian vaccination began in January 2021, aimed at priority groups. This study analysed the spatial and temporal evolution of vaccination in Brazil between the 3rd and 21st epidemiological weeks (EW) of 2021.

METHODS:

Spatial and temporal analyses were performed comprising 19 EW. Cases were structured into priority groups-elderly population (EP); healthcare workers (HW); indigenous and quilombola populations (I/Q), dose, vaccine (CoronaVac or AstraZeneca), and place of vaccination. A sweep test was performed to identify vaccination rate clusters. Vaccination rates (VR) were calculated according to a spatial window for each Health Region, indicating clusters above/below expected VR. Based on the discrete Poisson probability model, spatial analysis was performed to detect high/low VR clusters, which were converted into Kernel maps. Points were generated from SaTScan analyses associated with Health Region centroids. Temporal analysis of VR was carried out to identify significant trends, and results were converted into temporal cluster graphs. P-value ≤ 0.05 was adopted.

RESULTS:

Southeast region concentrated most of the vaccines of EP and HW, followed by the Northeast. The latter region had the largest contingent of I/Q vaccinated. In all priority age groups and all regions, a higher percentage of complete CoronaVac vaccination schedules were observed compared with AstraZeneca. The temporal analysis identified high VR clusters of CoronaVac first and second dose in the early weeks, except for the EP; of AstraZeneca first dose, only for HW in the early weeks, and for EP and I/Q in the final weeks; of AstraZeneca second dose for all priority groups in the final weeks. I/Q populations had the lowest general VR. The spatial profile of VR indicated significant regional cluster differences between the priority groups.

CONCLUSION:

This study highlights the importance of establishing vaccination priority groups, considering the asymmetries that a pandemic can trigger, notably in vast geographic areas, to contemplate the main objective of vaccination to prevent casualties.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Vaccines Limits: Aged / Humans Country/Region as subject: South America / Brazil Language: English Journal: BMC Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: S12879-022-07449-5

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Vaccines Limits: Aged / Humans Country/Region as subject: South America / Brazil Language: English Journal: BMC Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: S12879-022-07449-5